🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 500946108 (prev. 35803L108 )
- Market Cap
- Mid Cap
- IPO
- 10/3/2019 · $14.00/share
- Previous Symbol
- FREQ (changed 11/6/2023)
- Previous Name
- Frequency Therapeutics, Inc.
Business: Korro Bio, Inc. is a biopharmaceutical company with a mission to discover, develop and commercialize a new class of genetic medicines based on editing RNA, enabling treatment of both rare and highly prevalent diseases.
Notes: Jul. 14, 2023-- Korro Bio, Inc., a leading RNA editing company focused on the discovery and development of novel genetic medicines, and Frequency Therapeutics, Inc. (Nasdaq: FREQ) today announced that they have entered into a definitive merger agreement to combine the companies in an all-stock transaction. The combined company will focus on the advancement of Korro Bio’s portfolio of RNA editing programs, is expected to operate under Korro Bio, Inc. and will apply to trade on Nasdaq under the ticker symbol “KRRO”.
Company Contact
- CEO
- Ram Aiyar
- CFO
- Vineet Agarwal
- Headquarters
- One Kendall Square, Building 600-700, Suite 6-401, Cambridge, MA 02139
- Phone
- 617-468-1999
- Investor Relations
- 617-468-1999 · IR@korrobio.com